Financial statements Pharm Supply
Balance sheet data of PHARM SUPPLY
|
Year
|
2018
|
2019
|
2020
|
2021
|
2023
|
|---|---|---|---|---|---|
| Total assets | 16 103 003,47 | 18 176 934,28 | 16 172 579,18 | 13 568 360,32 | 17 130 461,47 |
| A. Fixed assets | 604 907,87 | 634 744,20 | 460 874,45 | 490 057,42 | 2 595 933,22 |
| B. Current assets | 15 498 095,60 | 17 542 190,08 | 15 711 704,73 | 13 078 302,90 | 14 534 528,25 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 16 103 003,47 | 18 176 934,28 | 16 172 579,18 | 13 568 360,32 | 17 130 461,47 |
| A. Equity | 15 487 396,41 | 15 320 502,51 | 15 374 738,64 | 12 738 343,37 | 11 357 422,75 |
| B. Liabilities and provisions for liabilities | 615 607,06 | 2 856 431,77 | 797 840,54 | 830 016,95 | 5 773 038,72 |
| I. Long-term liabilities | 213 612,76 | 227 771,47 | 77 494,10 | 163 426,79 | 1 702 441,65 |
| II. Short-term liabilities | 401 994,30 | 2 628 660,30 | 720 346,44 | 666 590,16 | 4 070 597,07 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.